NCT07615803

Brief Summary

This study was a cross-sectional, observational design without involving random grouping or intervention. From July 2026 to June 2027, 199 children with type 1 diabetes who had received insulin treatment for at least 6 months and their main family caregivers were recruited by a continuous enrollment method from the endocrinology department of a tertiary children's hospital in Zhejiang Province. Qualified investigators conducted on-site distribution and collection of structured questionnaires, collecting general information of the children, the occurrence of skin complications, and the insulin injection behaviors of the caregivers. At the same time, personnel with ultrasound qualifications used a wireless handheld ultrasound combined with a skin lipid caliper to uniformly measure the subcutaneous fat thickness at 8 sites including the abdomen, buttocks, arms, and thighs.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P50-P75 for all trials

Timeline
12mo left

Started Dec 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2026

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

May 29, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

April 30, 2026

Last Update Submit

May 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of insulin injection-related lipohypertrophy

    The proportion of children with type 1 diabetes who are identified as having insulin injection-related lipohypertrophy. Lipohypertrophy will be determined as present if it is detected by physical examination and/or ultrasound assessment; results from these assessments will be combined into a single yes/no determination for each participant and reported as a proportion.

    2026.07-2027.06

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Children diagnosed with type 1 diabetes and receiving insulin treatment, along with their primary family caregivers

You may qualify if:

  • Patient meets the diagnostic criteria for T1DM recommended by WHO and is diagnosed with T1DM.
  • Patient was diagnosed with T1DM for \>= 6 months.
  • Patient has no cognitive or awareness disorders and has the ability to read.
  • Patient agrees to participate in this study.
  • Patient's family caregiver has a certain level of comprehension ability, is conscious and clear-minded during the survey, and can answer freely.
  • Patient's family caregiver voluntarily participates in the survey.
  • Patient's family caregiver provides an average daily care time for the child of \>= 6 hours.

You may not qualify if:

  • Patient has acute or chronic complications of diabetes and is unable to cooperate, requiring urgent treatment.
  • Patient is in a state of disease stress, such as acute infection, surgery, trauma, etc., and is difficult to cooperate with the research.
  • Patient's family caregiver has unconsciousness or abnormal mental state.
  • Patient's family caregiver has hearing or language disorders.
  • Patient or patient's family caregiver has already participated in this survey.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes MellitusSkin Abnormalities

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

晓春 陈, bachelor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2026

First Posted

May 29, 2026

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

May 29, 2026

Record last verified: 2026-02